Cyndhavi Narayanan

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Theresa A. Storm, Patricia A. Lovelace, I. Weissman, 2017, Science Translational Medicine.

SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells

R. Majeti, E. Piccione, K. Weiskopf, 2016, Clinical Cancer Research.

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

I. Weissman, R. Majeti, M. Howard, 2015, PloS one.

A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells

R. Majeti, E. Piccione, C. Ryan, 2015, mAbs.

Overexpression of CD47 is associated with brain overgrowth in 16p11.2 deletion syndrome

I. Weissman, Sundari Chetty, Kristopher D. Marjon, 2019, bioRxiv.

A transient DMSO treatment increases the differentiation potential of human pluripotent stem cells through the Rb family

Sundari Chetty, Thomas Brickler, Jingling Li, 2018, PloS one.

Brief Report: Cell Cycle Dynamics of Human Pluripotent Stem Cells Primed for Differentiation

A. Kundaje, W. Greenleaf, A. Shcherbina, 2019, Stem cells.

Cell cycle dynamics of human pluripotent stem cells primed for differentiation

A. Kundaje, W. Greenleaf, A. Shcherbina, 2019, bioRxiv.

Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome

I. Weissman, Sundari Chetty, Kristopher D. Marjon, 2021, Proceedings of the National Academy of Sciences.